The global tildrakizumab market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tildrakizumab is a monoclonal antibody used to treat inflammatory diseases caused by the lack of immunity. Various diseases such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis can be treated with tildrakizumab (AS). One of the major factors driving the […]
